RankingsPricing
  1. US-listed companies
  2. INSMED Inc
  3. Financials
  4. Net income

INSMED IncINSM

Market cap
$41.3B
P/E ratio
SummaryFinancials
Period EndNet income (Million USD)YoY (%)
Dec 31, 2024-914+21.91%
Dec 31, 2023-750+55.66%
Dec 31, 2022-482+10.79%
Dec 31, 2021-435+47.80%
Dec 31, 2020-294+15.63%
Dec 31, 2019-254-21.57%
Dec 31, 2018-324+68.33%
Dec 31, 2017-193+9.29%
Dec 31, 2016-176+49.15%
Dec 31, 2015-118+49.30%
Dec 31, 2014-79+41.17%
Dec 31, 2013-56+35.53%
Dec 31, 2012-41-30.66%
Dec 31, 2011-60

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)